28 studies found for:    AD02 Alzheimer's
Show Display Options
RSS Create an RSS feed from your search for:
AD02 Alzheimer's
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Tolerability and Safety of Subcutaneous Administration of AFFITOPE AD02 in Mild to Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Biological: AFFITOPE AD02
2 Completed Clinical- and Immunological Activity, Safety and Tolerability of Different Doses / Formulations of AFFITOPE AD02 in Early Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Biological: active: AFFITOPE AD02;   Biological: control: Placebo
3 Terminated Follow-up Study to Assess Safety and Clinical Activity of Continued AFFITOPE® AD02 Vaccinations of Patients Who Participated in AFF006
Condition: Alzheimer´s Disease
Interventions: Biological: AFFITOPE® AD02;   Biological: Placebo
4 Completed Safety/Tolerability, Immunological and Clinical Activity of a Boost Immunization With AFFITOPE AD02
Condition: Alzheimer's Disease
Intervention: Biological: AFFITOPE AD02
5 Completed Long-term Safety and Tolerability of AFFITOPE AD02
Condition: Alzheimer's Disease
Intervention:
6 Terminated Observational Follow-up Extension Study of AFF002 and AFF004A in Patients With Alzheimer's Disease
Condition: Alzheimer´s Disease
Intervention:
7 Completed Improved Diagnosis of Alzheimer's Disease Using Magnetoencephalography (MEG)
Condition: Alzheimer's Disease
Intervention:
8 Completed Evaluation of E2609 in Subjects With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease (Study: E2609-A001-101 Amendment 02)
Condition: Alzheimer's Disease
Interventions: Drug: E2609;   Drug: Placebo for E2609
9 Recruiting A Phase IIa Multi-Center Study of 18F-FDG PET, Safety, and Tolerability of AZD0530 in Mild Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: AZD0530 100mg daily;   Drug: AZD0530 125mg daily;   Drug: Placebo
10 Completed Brain Imaging in Alzheimer's Disease
Condition: Alzheimer Disease
Intervention: Drug: [123] 5-I-A-85380
11 Completed Alzheimer's Disease Treatment and Illness Perceptions Survey (TIPS) II
Condition: Alzheimer Disease
Intervention:
12 Completed Alzheimer's Family Research
Condition: Decision Making
Intervention:
13 Completed Evaluation of Age- and Alzheimer's Disease-Related Memory Disorder
Conditions: Alzheimer Disease;   Dementia;   Memory Disorder;   Healthy
Intervention:
14 Recruiting Music Therapy in Alzheimer's Disease
Condition: Alzheimer's Type Dementia With Disruptive Behaviour
Interventions: Behavioral: Music therapy;   Behavioral: Placebo
15 Completed The Effect of Short-Term Statins and NSAIDs on Levels of Beta-Amyloid, a Protein Associated With Alzheimer's Disease
Condition: Alzheimer Disease
Interventions: Drug: Lovostatin;   Drug: Ibuprofen
16 Completed
Has Results
Fish Oil and Alpha Lipoic Acid in Treating Alzheimer's Disease
Conditions: Alzheimer's Disease;   Oxidative Stress;   Dementia;   Hyperlipidemia;   Inflammation
Interventions: Dietary Supplement: Fish Oil;   Dietary Supplement: Fish Oil and Lipoic acid;   Other: Placebo
17 Completed Physical Exercise as an Additional Treatment for Alzheimer Disease
Condition: Alzheimer Disease
Interventions: Behavioral: Aerobic Exercise;   Behavioral: Control Group
18 Completed TMS Stimulation and Cognitive Training in Alzheimer Patients
Conditions: Alzheimer Disease;   Mild to Moderate
Interventions: Device: Sham-NICE-System;   Device: NICE-System
19 Recruiting Health Technology Assessment of Diagnostic Approaches in Alzheimer's Disease
Conditions: Neurodegenerative Diseases;   Memory Disturbances
Intervention:
20 Completed Treatment Study of Frontotemporal Dementia
Condition: Frontotemporal Lobar Degeneration
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-28) Show next page of results    Last Page
Indicates status has not been verified in more than two years